Back to search
Disorder Due Cytochrome P450 CYP2D6 Variant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Disorder Due Cytochrome P450 CYP2D6 Variant trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Disorder Due Cytochrome P450 CYP2D6 Variant trials you may qualify forThe CYP 2D6 enzyme metabolizes a significant number of drugs frequently prescribed in general practice/ family medicine. Various genetically different variants…
Patients meeting eligibility criteria will be randomized into two groups, one receiving pharmacogenetic testing and the other not receiving pharmacogenetic test…
Depression is common among elderly with an estimated prevalence of 5%. Due to ageing the national burden will double in the coming decade. Antidepressants as TC…
This multicenter observational study aims to investigate the benefits of providing pharmacogenetic testing with the YouScript Personalized Prescribing System wh…
This randomized controlled trial will evaluate whether the use of pharmacogenetic testing through a Medication Therapy Management (MTM) program has a beneficial…
Aim of the study is the clinical validation of the metabolism and the pharmakokinetic of Clomifen in correlation to CYP2D6 and inhibition of CYP3A4.